| PESAA05 | Activation of anti-viral innate immunity in epithelial cells as a potential cellular mechanism for preferential R5 transmission at genital mucosa | Poster exhibition | HIV transmission and dissemination |
| PESAA06 | Dual role of HIV-1 Envelope Signal Peptide in immune evasion | Poster exhibition | HIV transmission and dissemination |
| PESAA07 | Overt IL-32 isoform expression at intestinal level during HIV-1 Infection is negatively regulated by IL-17A via PPAR gamma and retinoic acid-dependent mechanisms | Poster exhibition | Systemic immune activation and inflammation |
| PESAA08 | Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa | Poster exhibition | HIV transmission and dissemination |
| PESAA09 | Excess BAFF alters the Breg potential of human marginal zone B-cells in the context of HIV-1 infection | Poster exhibition | Systemic immune activation and inflammation |
| PESAA10 | Cerebrospinal fluid cellular inflammatory gene expression profile in people with acute HIV-1 infection | Poster exhibition | Systemic immune activation and inflammation |
| PESAA11 | A longitudinal assessment of the impact of antiretroviral therapy and HIV-1 associated inflammation on neurocognitive outcomes in perinatally infected (PHIV) children in South Africa | Poster exhibition | Systemic immune activation and inflammation |
| PESAA12 | No evidence that ongoing HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term suppressive ART | Poster exhibition | Systemic immune activation and inflammation |
| PESAA13 | Soluble interferon receptor (sIFNAR2) inhibits HIV-1 infection in macrophages through IFN-β-independent pathways | Poster exhibition | Innate immunity (including NK cells) |
| PESAB01 | Successful recruitment of Youth with untreated HIV infection in Adolescent Trials Network 147: early treatment of acute HIV infection | Poster exhibition | Acute and early infection |